Cardiovascular actions of galanin

Annals of the New York Academy of Sciences

Volumn 863, Issue , 1998, Pages 170-174

  Potter, Erica ^a  

^a PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GALANIN; GALANIN DERIVATIVE;

ANIMAL EXPERIMENT; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR FUNCTION; CAT; CONFERENCE PAPER; CONTROLLED STUDY; DEPRESSOR RESPONSE; DOG; INTRAVENOUS DRUG ADMINISTRATION; NERVE STIMULATION; NEUROMODULATION; NEUROTRANSMISSION; NONHUMAN; OPOSSUM; PULSE RATE; VAGUS NERVE;

ANIMALIA; CANIS FAMILIARIS; DIDELPHIDAE; FELIS CATUS;

EID: 0032447609     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1998.tb10693.x     Document Type: Conference Paper

References (16)

1. 1. POTTER, E.K. 1985. Prolonged non-adrenergic inhibition of cardiac vagal action following sympathetic stimulation. Neurosci. Lett. 54: 117-121.
2. 2. POTTER, E.K. 1987. Presynaptic inhibition of cardiac vagal postganglionic nerves by neuropeptide Y. Neurosci. Lett. 83: 101-106.
3. 3. TATEMOTO, K. 1982. Neuropeptide Y: The complete amino acid sequence of the brain peptide. Proc. Natl. Acad.Sci. USA 79: 5485-5489.
4. 4. KUMMER, W. 1987. Galanin-and neuropeptide Y-like immunoreactivities coexist in paravertebral sympathetic neurones of the cat. Neurosci. Lett. 78: 127-131.
5. 5. MORTARTY, M., I.L, GIBBINS, E.K. POTTER & D.I. MCCLOSKEY. 1992. Comparison of the inhibitory roles of neuropeptide Y and galanin on cardiac vagal action in the dog. Neurosci. Lett. 136: 275-279.
6. 6. MORRIS, J.L., I.L. GIBBINS & R. MURPHY. 1986. Neuropeptide Y-Iike immunoreactivity is absent from most perivascular noradrenergic axons in a marsupial, the brush-tailed possum. Neurosci. Lett. 71: 264-270.
7. 7. REVINGTON, M.L., E.K. POTTER & D.I. MCCLOSKEY. 1990. Prolonged inhibition of cardiac vagal action following sympathetic stimulation and galanin in anaesthetised cats. J. Physiol. 431: 495-503.
8. 8. ULMAN. L.G., H.F. EVANS, T.P. IISMAA, E.K. POTTER, D.I. MCCLOSKEY & J. SHINE. 1992. Effects of human, rat and porcine galanins on cardiac vagal action and blood pressure in the anaesthetised cat. Neurosci. Lett. 136: 105-108.
9. 9. COURTICE, G.P., E.K. POTTER & D.I. MCCLOSKEY. 1993. Inhibition of cardiac vagal action by galanin but not neuropeptide Y in the brush tailed possum Trichosurus vulpecula. J. Physiol. 461: 379-386.
10. 10. LINDSKOG, S., B. AHRÉN, T. LAND, U. LANGEL & T. BARTFAI. 1992. The novel high affinity antagonist galantide blocks the galanin mediated inhibition of glucose-induced insulin secretion. Eur. J. Pharmacol. 210: 183-188.
11. 11. CRAWLEY, J.N., J.K. ROBINSON, U. LANGEL & T. BARTFAI. 1993. Galanin receptor antagonists M40 and C7 block galanin induced feeding. Brain Res. 600: 268-272.
12. 12. ULMAN, L.G., E.K. POTTER & D.I. MCCLOSKEY. 1993. The effects of galanin and galanin fragments on cardiac vagal action and blood pressure in the anaesthetised cat. Reg. Pept. 44: 85-92.
13. 13. WANG, S., C. HE, T. HASHEMI & M. BAYNE. 1997. Cloning and expressional characterisation of a novel galanin receptor. Identification of different pharmacophores within galanin for the three galanin receptor subtypes. J. Biol. Chem. 272: 31949-31952.
14. 14. ULMAN, L.G., E.K. POTTER & D.I. MCCLOSKEY. 1994. Functional effects of a family of galanin antagonists on the cardiovascular system in anaesthetised cats. Reg. Pept. 51: 17-23.
15. 15. ULMAN, L.G., M. MORIARTY, E.K. POTTER & D.I. MCCLOSKEY. 1993. Galanin antagonist effects on cardiac vagal inhibitory actions of sympathetic stimulation in anaesthetised cats and dogs. J. Physiol. 464: 491-499.
16. 16. CAREY, D.G., T.P. IISMAA, K.Y. HO, I.A. RAIKOVIC, J. KELLY, E.W. KRAEGEN, J. FERGUSON, A.S. INGLIS, J. SHINE & D.J. CHISHOLM. 1993. Potent effects of human galanin in man: Growth hormone secretion and vagal blockade. J. Clin. Endocrinol. Metab. 77: 90-93.